- About
- Projects
- Column 1
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
- Food & Nutrition
- Column 2
- Column 1
- News and Events
- Expanded Access eRequest
Coverage
We will share key learnings related to the design of our Phase 2b PRIZM study in MELAS at the primary mitochondrial diseases public workshop, hosted by the Reagan-Udall Foundation for the FDA.
The agency’s lack of resources was documented in the Reagan Udall Foundation’s 2022 operational evaluation of the FDA’s Human Foods Program, an assessment former FDA Commissioner Robert Califf requested to help the agency make changes to better carry…
Dr. David Fajgenbaum was a third-year medical student when he “got critically ill out of nowhere.
Dr. Sumbul Desai’s job is to think creatively about the different ways that technology can improve health.
Georges C. Benjamin, M.D., is a well – known health policy leader, practitioner and administrator. He currently serves as the executive director of the American Public Health Association, the nation’s oldest and largest organization of public health…
I am delighted to share that Reed V. Tuckson, MD, FACP, yesterday received the 2025 Elizabeth Fries Health Education Award at the annual meeting of the Society for Public Health Education (SOPHE).
In 2023, the Reagan-Udall Foundation published plans for a public private partnership with industry to voluntarily collect data on the use of antimicrobials in farm animals.
Zeroing in on what is needed to improve operations, including the PMTA process, Booth said a review of the Reagan-Udall Foundation report is critical.
In addition to the new AACR award, Dr. Pazdur has received numerous awards and honors throughout his career: the Regulatory Affairs Professionals Society Patient-Centered Health Award (2021), the University of Chicago Cancer Research Foundation Simon M…
In 2022, the FDA requested the Reagan Udall Foundation conduct an independent investigation of the CTP. The resulting report highlighted several shortcomings, including a lack of a clear regulatory and product approval framework, an inefficient and slow…